Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Irbesartan 150mg Verses 300mg in Chinese Hypertensive Patients With Diabetes and Microalbuminuria

NCT00334581 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00334581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00334581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Irbesartan 150mg Verses 300mg in Chinese Hypertensive Patients With Diabetes and Microalbuminuria
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
June 30, 2008
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension